JP2013224953A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013224953A5 JP2013224953A5 JP2013133614A JP2013133614A JP2013224953A5 JP 2013224953 A5 JP2013224953 A5 JP 2013224953A5 JP 2013133614 A JP2013133614 A JP 2013133614A JP 2013133614 A JP2013133614 A JP 2013133614A JP 2013224953 A5 JP2013224953 A5 JP 2013224953A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- use according
- cells
- nucleoside
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66510505P | 2005-03-25 | 2005-03-25 | |
| US60/665,105 | 2005-03-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503271A Division JP2008536822A (ja) | 2005-03-25 | 2006-03-27 | テロメラーゼ陽性細胞におけるテロメア長の調節および癌治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013224953A JP2013224953A (ja) | 2013-10-31 |
| JP2013224953A5 true JP2013224953A5 (https=) | 2014-05-22 |
Family
ID=37053967
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503271A Pending JP2008536822A (ja) | 2005-03-25 | 2006-03-27 | テロメラーゼ陽性細胞におけるテロメア長の調節および癌治療 |
| JP2013133614A Pending JP2013224953A (ja) | 2005-03-25 | 2013-06-26 | テロメラーゼ陽性細胞におけるテロメア長の調節および癌治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503271A Pending JP2008536822A (ja) | 2005-03-25 | 2006-03-27 | テロメラーゼ陽性細胞におけるテロメア長の調節および癌治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US7741296B2 (https=) |
| EP (1) | EP1868615A4 (https=) |
| JP (2) | JP2008536822A (https=) |
| CN (2) | CN104997783A (https=) |
| CA (1) | CA2602562C (https=) |
| WO (1) | WO2006104975A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050113324A1 (en) * | 2003-01-15 | 2005-05-26 | Bondarev Igor E. | Modulation of line-1 reverse transcriptase |
| CN101588805A (zh) * | 2005-05-18 | 2009-11-25 | Alt解决方案公司 | 为预防和治疗癌症对癌细胞中端粒长度的药理学调节 |
| WO2007106561A2 (en) * | 2006-03-14 | 2007-09-20 | Alt Solutions, Inc. | Prevention and treatment of cancer and other diseases |
| ES2874774T3 (es) | 2011-12-22 | 2021-11-05 | Geron Corp | Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros |
| CN102660650A (zh) * | 2012-05-25 | 2012-09-12 | 云南路易斯中药现代化工程技术研究中心 | 一种实时定量pcr测量样品中染色体端粒平均长度的绝对值的试剂盒及应用 |
| CA2892445C (en) * | 2012-11-30 | 2022-06-28 | Geron Corporation | Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors |
| US9795242B2 (en) | 2013-02-14 | 2017-10-24 | Cirkul, Inc. | Additive delivery systems and containers |
| US10888826B2 (en) | 2014-11-21 | 2021-01-12 | Cirkul, Inc. | Adjustable additive cartridge systems and methods |
| JP6730298B2 (ja) | 2014-11-21 | 2020-07-29 | サークル, インコーポレイテッド.Cirkul, Inc. | 添加剤カートリッジ及び添加剤供給システム |
| EP3753563A1 (en) * | 2019-06-20 | 2020-12-23 | Helmholtz-Zentrum für Infektionsforschung GmbH | Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy |
| CN112168829B (zh) * | 2020-09-24 | 2022-02-15 | 华南理工大学 | 抗病毒药物在制备治疗骨髓增生异常综合征药物中的应用及制得的骨髓增生异常综合征药物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585363A (en) * | 1987-05-05 | 1996-12-17 | City Of Hope | Circumvention of human tumor drug resistance |
| US5166140A (en) * | 1987-05-05 | 1992-11-24 | City Of Hope | Use of certain nucleoside analogs to attenuate cancer cell resistance to DNA damaging chemotherapy |
| US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| US5654286A (en) * | 1993-05-12 | 1997-08-05 | Hostetler; Karl Y. | Nucleotides for topical treatment of psoriasis, and methods for using same |
| US5631236A (en) * | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| WO1997021452A2 (en) * | 1995-12-14 | 1997-06-19 | Advanced Magnetics, Inc. | Macromolecular prodrugs of nucleotide analogs |
| GB9601544D0 (en) * | 1996-01-26 | 1996-03-27 | Smithkline Beecham Plc | Pharmaceuticals |
| ATE462447T1 (de) * | 1999-06-23 | 2010-04-15 | Univ Vermont | Verfahren und mittels zur manipulierung der expression des uncoupling proteins |
| US20050113324A1 (en) * | 2003-01-15 | 2005-05-26 | Bondarev Igor E. | Modulation of line-1 reverse transcriptase |
-
2006
- 2006-03-27 CA CA2602562A patent/CA2602562C/en not_active Expired - Fee Related
- 2006-03-27 CN CN201510092529.5A patent/CN104997783A/zh active Pending
- 2006-03-27 WO PCT/US2006/011027 patent/WO2006104975A2/en not_active Ceased
- 2006-03-27 US US11/886,446 patent/US7741296B2/en not_active Expired - Fee Related
- 2006-03-27 JP JP2008503271A patent/JP2008536822A/ja active Pending
- 2006-03-27 EP EP06748718A patent/EP1868615A4/en not_active Withdrawn
- 2006-03-27 CN CNA200680015221XA patent/CN101193643A/zh active Pending
-
2010
- 2010-05-12 US US12/662,939 patent/US8097595B2/en not_active Expired - Fee Related
-
2012
- 2012-01-06 US US13/344,651 patent/US8580753B2/en not_active Expired - Fee Related
-
2013
- 2013-06-26 JP JP2013133614A patent/JP2013224953A/ja active Pending
- 2013-11-11 US US14/076,518 patent/US20140065072A1/en not_active Abandoned
-
2015
- 2015-09-17 US US14/856,122 patent/US20160000937A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013224953A5 (https=) | ||
| WO2013167743A1 (en) | Use of compounds for the treatment of pain | |
| ES2251168T3 (es) | Agente antiviral en combinacion con radioterapia para el tratamiento del cancer. | |
| US20150290235A1 (en) | Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections | |
| ES2982897T3 (es) | Uso del inhibidor de la telomerasa imetelstat para el tratamiento de trastornos mieloproliferativos y neoplasias mieloproliferativas | |
| EA019869B1 (ru) | Низкомолекулярные миристатные ингибиторы тирозинкиназы bcr-abl и способы их применения | |
| RU2011134499A (ru) | Композиция 4-амино-2-(2,6-диоксопиперидин-3-ил)изоиндолин-1,3-диона | |
| HK1200716A1 (zh) | 使用胞苷類似物的口服製劑治療癌症的方法 | |
| Ray et al. | Application of kinase bypass strategies to nucleoside antivirals | |
| JP2009530295A5 (https=) | ||
| RU2018138976A (ru) | Лечение рака головного мозга | |
| JP2014144962A5 (https=) | ||
| CN110769837A (zh) | 与五氮杂大环状环配合物的联合癌症免疫疗法 | |
| De Clercq | The Holý Trinity: the acyclic nucleoside phosphonates | |
| JP2014513705A (ja) | 進行性固形腫瘍の治療方法 | |
| IL193148A (en) | Medicine combined with hepatitis B virus | |
| CA2644297A1 (en) | Prevention and treatment of cancer and other diseases | |
| HK1256891A1 (zh) | 治疗逆转录病毒感染的方法和相关剂量方案 | |
| Rawal et al. | 2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action | |
| WO2011011710A1 (en) | Methods of treating viral infections | |
| CA2868024A1 (en) | Methods of treating cancer using aurora kinase inhibitors | |
| CN102905709B (zh) | 同时、单独或相继用于治疗和/或预防和/或减轻癌症的egfr抑制剂和抗病毒剂 | |
| CN118176201B (zh) | L-bhdu的前药和治疗病毒感染的方法 | |
| US20150110864A1 (en) | Novel antitumor agent comprising combination of three agents | |
| CN101031308A (zh) | 由rna依赖性dna聚合酶活化的药物前体 |